We have observed
13 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after September 17, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
ANTIBODIES SELECTIVE FOR CELLS PRESENTING EGFR AT HIGH DENSITY
PLANTS HAVING ENHANCED YIELD-RELATED TRAITS AND METHOD FOR MAKING THE SAME
Plants having enhanced yield-related traits and a method for making the same
PLANTS HAVING ENCHANCED YIELD-RELATED TRAITS AND METHOD FOR MAKING THE SAME
METHODS AND COMPOSITIONS FOR GENERATING PANCREATIC PROGENITORS AND FUNCTIONAL BETA CELLS FROM hPSCs
PLANTS HAVING ENHANCED ABIOTIC STRESS TOLERANCE AND/OR ENHANCED YIELD-RELATED TRAITS AND A METHOD FOR MAKING THE SAME
CARTILAGE COMPOSITIONS AND METHODS FOR MODIFYING PROTEOGLYCAN CONTENT
CONJUGATES FOR THE TREATMENT OF CANCER TARGETED AT INTRACELLULAR TUMOR-ASSOCIATED ANTIGENS
PROCESS FOR PREPARING FORM A OF GRAPIPRANT
HERBAL COMPOSITION FOR TREATMENT OF BACK PAIN
PEPTIDE-POLYNUCLEOTIDE COMPLEX FOR POLYNUCLEOTIDE TRANSFECTION
COMPOSITIONS AND METHODS OF USE OF ANTIBACTERIAL DRUG COMBINATIONS